Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Update

Scienture Holdings, Inc. (NASDAQ:SCNX) was the target of a large increase in short interest in January. As of January 15th, there was short interest totaling 3,504,653 shares, an increase of 46.2% from the December 31st total of 2,397,102 shares. Approximately 11.0% of the shares of the stock are sold short. Based on an average daily volume of 2,225,372 shares, the days-to-cover ratio is presently 1.6 days. Based on an average daily volume of 2,225,372 shares, the days-to-cover ratio is presently 1.6 days. Approximately 11.0% of the shares of the stock are sold short.

Scienture Stock Performance

SCNX stock opened at $0.45 on Tuesday. The company has a market capitalization of $18.39 million, a P/E ratio of -0.45 and a beta of 3.02. The company has a fifty day moving average price of $0.54 and a 200-day moving average price of $0.92. Scienture has a 52-week low of $0.43 and a 52-week high of $3.90.

Scienture (NASDAQ:SCNX) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($0.19) earnings per share for the quarter. The company had revenue of $0.59 million during the quarter.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Wall Street Zen cut shares of Scienture from a “hold” rating to a “sell” rating in a research note on Sunday, January 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Scienture in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.